Phentermine and tirzepatide represent two distinct pharmacological approaches to weight management, each with unique mechanisms of action and clinical applications
GLP-1 receptor agonists are licensed in the UK for type 2 diabetes and weight management, including semaglutide, dulaglutide, and liraglutide These medications reduce HbA1c by approximately 1.01.5 percentage points and improve both fasting and post-meal glucose levels Weight loss associated with GLP-1 therapy can lead to secondary improvements in insulin resistance, particularly through reduction of visceral fat Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhoea, which typically diminish over several weeks NICE recommends continuation only if patients achieve at least 1.0 percentage point HbA1c reduction within six months of treatment initiation Patients with diabetic retinopathy require close monitoring, and GLP-1 medications should be discontinued at least two months before planned pregnancy Table of Contents What Are GLP-1 Receptor Agonists and How Do They Work
Postpartum Weight Retention Risk Factors and Relationship to Obesity at 1 Year
If you're already dealing with bloating, nausea, or a slow stomach from GLP-1 weight-loss medications like Ozempic or Mounjaro , clear liquids pass through you much faster
The mechanisms underlying this superior effect involve both additive and combined effects
While it isn't a quick-fix painkiller, consistent use can help your body recover more quickly from the inflammatory peak of your cycle
